Redmond Asset Management, LLC Black Diamond Therapeutics, Inc. Transaction History

Redmond Asset Management, LLC

  • $386 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.68 - $4.01 $48 - $116
-29 Reduced 0.18%
15,978 $27,000
Q1 2022

May 03, 2022
BUY
$2.66 - $5.61 $119 - $252
45 Added 0.28%
16,007 $44,000
Q4 2021

Feb 04, 2022
BUY
$5.18 - $8.48 $1,704 - $2,789
329 Added 2.1%
15,962 $85,000
Q1 2021

May 06, 2021
BUY
$22.23 - $34.75 $347,521 - $543,246
15,633 New
15,633 $379,000

Others Institutions Holding BDTX

# of Institutions
94
Shares Held
47.6M
Call Options Held
2.9K
Put Options Held
69.4K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $68.3M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email